Prestige Consumer Healthcare Inc (PBH)
63.83
-0.90
(-1.39%)
USD |
NYSE |
May 23, 16:00
63.82
-0.01
(-0.02%)
Pre-Market: 20:00
Prestige Consumer Healthcare Free Cash Flow: 239.38M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | 239.38M |
December 31, 2023 | 232.04M |
September 30, 2023 | 215.70M |
June 30, 2023 | 211.34M |
March 31, 2023 | 221.93M |
December 31, 2022 | 225.47M |
September 30, 2022 | 236.40M |
June 30, 2022 | 239.68M |
March 31, 2022 | 250.28M |
December 31, 2021 | 244.51M |
September 30, 2021 | 223.94M |
June 30, 2021 | 208.57M |
March 31, 2021 | 213.36M |
December 31, 2020 | 209.79M |
September 30, 2020 | 221.06M |
June 30, 2020 | 224.34M |
March 31, 2020 | 202.56M |
December 31, 2019 | 199.45M |
September 30, 2019 | 185.95M |
June 30, 2019 | 176.24M |
March 31, 2019 | 178.80M |
December 31, 2018 | 182.86M |
September 30, 2018 | 183.86M |
June 30, 2018 | 199.39M |
March 31, 2018 | 197.58M |
Date | Value |
---|---|
December 31, 2017 | 152.50M |
September 30, 2017 | 149.77M |
June 30, 2017 | 146.86M |
March 31, 2017 | 145.70M |
December 31, 2016 | 178.04M |
September 30, 2016 | 183.51M |
June 30, 2016 | 180.41M |
March 31, 2016 | 172.74M |
December 31, 2015 | 183.62M |
September 30, 2015 | 183.38M |
June 30, 2015 | 163.72M |
March 31, 2015 | 150.15M |
December 31, 2014 | 131.06M |
September 30, 2014 | 111.22M |
June 30, 2014 | 116.56M |
March 31, 2014 | 108.82M |
December 31, 2013 | 113.58M |
September 30, 2013 | 125.51M |
June 30, 2013 | 135.23M |
March 31, 2013 | 127.34M |
December 31, 2012 | 111.16M |
September 30, 2012 | 88.80M |
June 30, 2012 | 65.02M |
March 31, 2012 | 66.85M |
December 31, 2011 | 72.40M |
Free Cash Flow Range, Past 5 Years
176.24M
Minimum
Jun 2019
250.28M
Maximum
Mar 2022
219.10M
Average
221.50M
Median
Free Cash Flow Benchmarks
Arcutis Biotherapeutics Inc | -198.32M |
NovaBay Pharmaceuticals Inc | -4.524M |
Palatin Technologies Inc | -33.83M |
iBio Inc | -18.67M |
Theriva Biologics Inc | -18.27M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 66.91M |
Cash from Investing (Quarterly) | -15.00M |
Cash from Financing (Quarterly) | -68.44M |
Free Cash Flow Per Share (Quarterly) | 1.267 |
Free Cash Flow to Equity (Quarterly) | 137.30M |
Free Cash Flow to Firm (Quarterly) | 74.97M |
Free Cash Flow Yield | 7.47% |